Cover Image
市場調查報告書

貝爾氏麻痺:主要15個國家的市場預測

Epiomic Epidemiology Series: Bell's Palsy Forecast in 15 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 436080
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
貝爾氏麻痺:主要15個國家的市場預測 Epiomic Epidemiology Series: Bell's Palsy Forecast in 15 Major Markets 2017-2027
出版日期: 2017年02月01日 內容資訊: 英文 62 Pages
簡介

本報告提供全球主要15個國家的貝爾氏麻痺 (面部神經麻痺)的發病情形相關分析,疾病概要和目前的患病人數,性別、各年代 (5歲區分)的詳細情況,各地區、各民族趨勢,風險要素,疾病診斷與預後,主要的症狀和併發症,未來趨勢預測 (今後10年份) 的資訊彙整,為您概述為以下內容。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要的共生病症/特徵
  • 患者數的測量方法
  • 貝爾氏麻痺的最大患病人數
  • 貝爾氏麻痺患者的特徵
  • 貝爾氏麻痺的復發
  • 貝爾氏麻痺患者的後遺症、特徵
  • 貝爾氏麻痺患者的共生病症
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

表格一覽

分析觀察對象國家

  • 巴西、加拿大、中國、丹麥、埃及、法國、德國、義大利、日本、墨西哥、韓國、西班牙、土耳其、英國、美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BPLS0010217

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bell's palsy in 15 Major Markets

Bell's palsy, also known as idiopathic facial nerve palsy, is a weakness of the muscles on one side of the face caused by the compression of the facial/cranial nerve, with no known underlying pathological cause. Such a condition typically manifests in a unilateral paralysis of the face. In rare cases, both sides of the face can be affected. Bell's palsy is characterised by its rapid onset, reaching clinical peak within 72 hours. Most patients fully recover from Bell's palsy.

This report provides the current incident population for Bell's palsy across 15 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, China, Turkey, Mexico, Denmark, Egypt and South Korea) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Bell's palsy have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Bell's palsy include:

  • Rapid onset of mild weakness to total paralysis on one side of the face
  • Facial droop
  • Drooling
  • Increased sensitivity to sound on the affected side
  • Headache
  • Synkinesis (involuntary facial movement)
  • Decrease in taste sensations
  • Pain around the jaw
  • Pain behind the ear on the affected side
  • Change in volume of tears/saliva that the individual may produce

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Bell's palsy market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Bell's palsy and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Bell's palsy incident population.
  • Identify sub-populations within Bell's palsy which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Bell's palsy patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line incidence for Bell's palsy
  • Features of Bell's palsy patients
  • Recurrence of Bell's palsy
  • Sequelae and features of Bell's palsy patients
  • Co-morbidities of patients with Bell's palsy
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • The House-Brackmann Facial Nerve Grading System
  • Incidence of Bell's palsy, total (000s)
  • Incidence of Bell's palsy, males (000s)
  • Incidence of Bell's palsy, females (000s)
  • Bell's palsy patients by House-Brackmann Grade (at Onset), total (000s)
  • Completeness of paralysis of face, total (000s)
  • Recovery of Bell's palsy patients, total (000s)
  • Bell's palsy patients experiencing recurrence, total (000s)
  • Patients with recurrent Bell's palsy by number of recurrent episodes, total (000s)
  • Bell's palsy patients that develop sequelae, total (000s)
  • Severity of Sequelae, total (000s)
  • Bell's palsy patients with hypertension, total (000s)
  • Bell's palsy patients with diabetes mellitus, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • USA Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Canada Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Canada Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • France Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • France Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Germany Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Germany Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Italy Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Italy Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Spain Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Spain Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • UK Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • UK Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Brazil Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Brazil Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Japan Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Japan Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • China Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • China Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Turkey Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Turkey Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Denmark Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Denmark Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Mexico Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Mexico Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • Egypt Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • Egypt Incidence of Bell's palsy by 5-yr age cohort, females (000s)
  • South Korea Incidence of Bell's palsy by 5-yr age cohort, males (000s)
  • South Korea Incidence of Bell's palsy by 5-yr age cohort, females (000s)
Back to Top